Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943211708> ?p ?o ?g. }
- W2943211708 endingPage "679" @default.
- W2943211708 startingPage "679" @default.
- W2943211708 abstract "<h3>Importance</h3> The lymphatic and the hematogenous pathways have been proposed for disease progression in cutaneous melanoma, but association with recurrence has not been studied separately to date. <h3>Objective</h3> To identify the risk factors associated with lymphatic and hematogenous metastasis. <h3>Design, Setting, and Participants</h3> This retrospective cohort study included 1177 patients with malignant melanoma treated at Instituto Valenciano de Oncología, València, Spain. Data were retrieved from the melanoma database from January 1, 2000, through December 31, 2015, and analyzed from June 1 to 30, 2018. <h3>Exposure</h3> Malignant melanoma at stages I to II. <h3>Main Outcomes and Measures</h3> Analyses of survival free of lymphatic and hematogenous metastasis were performed using Kaplan-Meier curves and Cox proportional hazards regression. <h3>Results</h3> For the 1177 patients included in the study analysis (51.1% women; median age at diagnosis, 55 years [interquartile range, 42-68 years), median follow-up was 75 months (interquartile range, 33-121 months); 108 (9.2%) developed lymphatic metastasis, and 108 (9.2%) developed hematogenous metastasis. In the multivariate analysis, being older than 55 years (hazard ratio [HR], 1.9; 95% CI, 1.2-3.1), tumor in the head/neck (HR, 1.7; 95% CI, 1.0-2.9) and acral locations (HR, 2.4; 95% CI, 1.3-4.5), greater Breslow thickness (HR for >4.00 mm, 5.4; 95% CI, 2.4-12.4), and presence of vascular invasion (HR, 3.2; 95% CI, 0.9-10.6) were associated with lymphatic spreading. Hematogenous metastasis was associated with greater Breslow thickness (HR for >4.00 mm, 10.4; 95% CI, 3.6-29.7), the absence of regression (HR, 0.1; 95% CI, 0.0-1.0),<i>TERT</i>promoter mutations (HR, 2.9; 95% CI, 1.5-5.7), and<i>BRAF</i>mutations (HR, 1.9; 95% CI, 1.1-3.6). <h3>Conclusions and Relevance</h3> Risk factors associated with lymphatic and hematogenous metastasis differ. Follow-up and adjuvant treatment strategies may therefore need to be adapted to individual clinical, histopathologic, and molecular characteristics." @default.
- W2943211708 created "2019-05-09" @default.
- W2943211708 creator A5000360051 @default.
- W2943211708 creator A5001178077 @default.
- W2943211708 creator A5003428500 @default.
- W2943211708 creator A5022884757 @default.
- W2943211708 creator A5051929179 @default.
- W2943211708 creator A5054289982 @default.
- W2943211708 creator A5065248608 @default.
- W2943211708 creator A5068410326 @default.
- W2943211708 creator A5082432530 @default.
- W2943211708 date "2019-06-01" @default.
- W2943211708 modified "2023-10-15" @default.
- W2943211708 title "Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma" @default.
- W2943211708 cites W1545734177 @default.
- W2943211708 cites W1965784563 @default.
- W2943211708 cites W1966439727 @default.
- W2943211708 cites W1967365463 @default.
- W2943211708 cites W1967557699 @default.
- W2943211708 cites W1981876977 @default.
- W2943211708 cites W1983651665 @default.
- W2943211708 cites W1985148437 @default.
- W2943211708 cites W1985198734 @default.
- W2943211708 cites W1992576904 @default.
- W2943211708 cites W1993497779 @default.
- W2943211708 cites W1997864198 @default.
- W2943211708 cites W1999061274 @default.
- W2943211708 cites W1999083651 @default.
- W2943211708 cites W2000521267 @default.
- W2943211708 cites W2004547119 @default.
- W2943211708 cites W2006150791 @default.
- W2943211708 cites W2018005699 @default.
- W2943211708 cites W2021953626 @default.
- W2943211708 cites W2031216366 @default.
- W2943211708 cites W2031259832 @default.
- W2943211708 cites W2032924611 @default.
- W2943211708 cites W2033643151 @default.
- W2943211708 cites W2042475475 @default.
- W2943211708 cites W2049073719 @default.
- W2943211708 cites W2051453426 @default.
- W2943211708 cites W2064977866 @default.
- W2943211708 cites W2080220542 @default.
- W2943211708 cites W2081255111 @default.
- W2943211708 cites W2095362763 @default.
- W2943211708 cites W2105621368 @default.
- W2943211708 cites W2112227821 @default.
- W2943211708 cites W2118863192 @default.
- W2943211708 cites W2127858747 @default.
- W2943211708 cites W2145469843 @default.
- W2943211708 cites W2145956339 @default.
- W2943211708 cites W2161817637 @default.
- W2943211708 cites W2189916683 @default.
- W2943211708 cites W2212582320 @default.
- W2943211708 cites W2253355571 @default.
- W2943211708 cites W2269918986 @default.
- W2943211708 cites W2311903371 @default.
- W2943211708 cites W2532800894 @default.
- W2943211708 cites W4239350384 @default.
- W2943211708 cites W4239851916 @default.
- W2943211708 cites W4239971456 @default.
- W2943211708 cites W4243015203 @default.
- W2943211708 cites W4245586245 @default.
- W2943211708 cites W4253165605 @default.
- W2943211708 cites W4256313481 @default.
- W2943211708 cites W76928992 @default.
- W2943211708 doi "https://doi.org/10.1001/jamadermatol.2019.0069" @default.
- W2943211708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6495361" @default.
- W2943211708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31042264" @default.
- W2943211708 hasPublicationYear "2019" @default.
- W2943211708 type Work @default.
- W2943211708 sameAs 2943211708 @default.
- W2943211708 citedByCount "19" @default.
- W2943211708 countsByYear W29432117082019 @default.
- W2943211708 countsByYear W29432117082020 @default.
- W2943211708 countsByYear W29432117082021 @default.
- W2943211708 countsByYear W29432117082022 @default.
- W2943211708 countsByYear W29432117082023 @default.
- W2943211708 crossrefType "journal-article" @default.
- W2943211708 hasAuthorship W2943211708A5000360051 @default.
- W2943211708 hasAuthorship W2943211708A5001178077 @default.
- W2943211708 hasAuthorship W2943211708A5003428500 @default.
- W2943211708 hasAuthorship W2943211708A5022884757 @default.
- W2943211708 hasAuthorship W2943211708A5051929179 @default.
- W2943211708 hasAuthorship W2943211708A5054289982 @default.
- W2943211708 hasAuthorship W2943211708A5065248608 @default.
- W2943211708 hasAuthorship W2943211708A5068410326 @default.
- W2943211708 hasAuthorship W2943211708A5082432530 @default.
- W2943211708 hasBestOaLocation W29432117081 @default.
- W2943211708 hasConcept C119060515 @default.
- W2943211708 hasConcept C121608353 @default.
- W2943211708 hasConcept C126322002 @default.
- W2943211708 hasConcept C141071460 @default.
- W2943211708 hasConcept C142724271 @default.
- W2943211708 hasConcept C143998085 @default.
- W2943211708 hasConcept C167135981 @default.
- W2943211708 hasConcept C181152851 @default.
- W2943211708 hasConcept C207103383 @default.
- W2943211708 hasConcept C2777658100 @default.